TRPV6 calcium channel translocates to the plasma membrane via Orai1-mediated mechanism and controls cancer cell survival

Significance Transient receptor potential vanilloid subfamily member 6 (TRPV6) is a highly selective Ca ²⁺ channel that exercises its normal physiological function via Ca ²⁺ absorption in the intestine and kidney. Intriguingly, we show that the TRPV6 channel may switch from its well-known constituti...

Full description

Saved in:
Bibliographic Details
Published inProceedings of the National Academy of Sciences - PNAS Vol. 111; no. 37; pp. E3870 - E3879
Main Authors Raphaël, Maylis, Lehen'kyi, V'yacheslav, Vandenberghe, Matthieu, Beck, Benjamin, Khalimonchyk, Sergiy, Vanden Abeele, Fabien, Farsetti, Leonardo, Germain, Emmanuelle, Bokhobza, Alexandre, Mihalache, Adriana, Gosset, Pierre, Romanin, Christoph, Clézardin, Philippe, Skryma, Roman, Prevarskaya, Natalia
Format Journal Article
LanguageEnglish
Published United States National Academy of Sciences 16.09.2014
National Acad Sciences
SeriesPNAS Plus
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Significance Transient receptor potential vanilloid subfamily member 6 (TRPV6) is a highly selective Ca ²⁺ channel that exercises its normal physiological function via Ca ²⁺ absorption in the intestine and kidney. Intriguingly, we show that the TRPV6 channel may switch from its well-known constitutive activity to the store operated due to the remodeling mechanism involving STIM1/Orai1/TRPC1-induced activation of TRPV6 channel translocation to the plasma membrane via the Ca ²⁺/Annexin I/S100A11 pathway. Moreover, we demonstrate that the discovered mechanism is used by prostate cancer cells. This channel is absent in healthy prostate and is expressed de novo in prostate cancer cells, where it changes the role by supplying Ca ²⁺, which is used in cancer to increase cell survival.
Bibliography:http://dx.doi.org/10.1073/pnas.1413409111
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMCID: PMC4169956
Author contributions: M.R., V.L., F.V.A., and N.P. designed research; V.L., P.G., C.R., P.C., and R.S. contributed new reagents/analytic tools; M.R., V.L., M.V., B.B., S.K., F.V.A., L.F., E.G., A.B., and A.M. performed research; M.R., V.L., M.V., B.B., S.K., F.V.A., L.F., E.G., A.M., P.G., C.R., P.C., and R.S. analyzed data; and V.L. and N.P. wrote the paper.
2V.L. and N.P. contributed equally to this work.
4Present address: Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire, Université Libre de Bruxelles, 1070 Bruxelles, Belgium.
1M.R., V.L., and M.V. contributed equally to this work.
Edited by Lutz Birnbaumer, National Institute of Environmental Health Sciences, Research Triangle Park, NC, and approved August 1, 2014 (received for review July 15, 2014)
3Present address: Department of Medicine, Dermatology Research, University of California, San Diego, La Jolla, CA 92121.
ISSN:0027-8424
1091-6490
DOI:10.1073/pnas.1413409111